RXRA and malignant colon neoplasm: Separately, RXRα also inhibits the transcription of ß-catenin and directly regulates the Wnt/β-catenin cascade in colon cancer cells suggesting RXRα–ß-catenin axis as a potential therapeutic target [94] (Fig. 2 (3)).